{
    "clinical_study": {
        "@rank": "25184", 
        "arm_group": [
            {
                "arm_group_label": "CT-P27 10mg/kg", 
                "arm_group_type": "Experimental", 
                "description": "CT-P27 10mg/kg IV in 90 minutes"
            }, 
            {
                "arm_group_label": "CT-P27 20mg/kg", 
                "arm_group_type": "Experimental", 
                "description": "CT-P27 20mg/kg IV in 90 minutes"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo IV in 90 minutes"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is to evaluate the efficacy of CT-P27 measured by quantitative PCR viral load\n      from nasopharyngeal mucosa, compared to placebo."
        }, 
        "brief_title": "To Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Influenza", 
        "condition_browse": {
            "mesh_term": "Influenza, Human"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy Male & Female volunteers\n\n        Exclusion Criteria:\n\n          -  Current clinically significant disease\n\n          -  Pregnant or nursing mother\n\n          -  Abnormal pulmonary function, nose or nasopharynx"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "81", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02071914", 
            "org_study_id": "CT-P27/2.1"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "CT-P27 10mg/kg", 
                    "CT-P27 20mg/kg"
                ], 
                "intervention_name": "CT-P27", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 24, 2014", 
        "location": {
            "contact": {
                "last_name": "Retroscreen", 
                "phone": "+44 (0)20 7756 1300"
            }, 
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "United Kingdom"
                }, 
                "name": "Retroscreen Virology Ltd."
            }, 
            "investigator": {
                "last_name": "Bryan J Murray, MBBS, RICR", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Randomised, Double-Blind, Placebo-Controlled, Single-Centre, Phase IIa Study in Healthy Volunteers to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "AUC of post-challenge nasopharyngeal viral load measured by quantitative PCR of nasopharyngeal swab", 
            "safety_issue": "No", 
            "time_frame": "three in a day from Day 1(the day after virus inoculation) to Day 9"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02071914"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Celltrion", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Celltrion", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}